Related Experiment Videos
Pulmonary dysfunction in systemic lupus erythematosus:prevalence classification and correlation with other organ
The Journal of Rheumatology
|March 1, 1980
Summary
Pulmonary function tests reveal significant lung issues in most systemic lupus erythematosus (SLE) patients. These tests effectively detect lung involvement, independent of lupus activity markers.
Area of Science:
- Rheumatology
- Pulmonology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with potential multi-organ involvement.
- Pulmonary complications are common in SLE but can be subclinical.
- Early detection of pulmonary dysfunction is crucial for patient management.
Purpose of the Study:
- To evaluate the prevalence and patterns of pulmonary dysfunction in patients with SLE.
- To assess the sensitivity of pulmonary function tests (PFTs) in detecting pulmonary involvement in SLE.
- To investigate the correlation between PFT abnormalities and other markers of SLE activity.
Main Methods:
- Pulmonary function evaluation was performed on 43 patients diagnosed with SLE.
- Data collected included diffusing capacity, lung volumes, arterial oxygen saturation, and airways resistance.
- Results were compared with clinical symptoms, chest radiography, serology, and biopsy findings.
Main Results:
- Pulmonary dysfunction was identified in 88% of the patients studied.
- Impaired diffusing capacity was the most frequent abnormality (72%), followed by reduced lung volumes (49%) and hypoxia (44%).
- PFTs demonstrated higher sensitivity in detecting pulmonary involvement compared to clinical signs or chest X-rays.
Conclusions:
- Pulmonary dysfunction is highly prevalent in SLE patients, often manifesting as impaired diffusing capacity.
- Pulmonary function tests are essential for sensitive detection of lung involvement in SLE.
- No correlation was observed between the severity of pulmonary dysfunction and other SLE activity markers.